Related Experiment Videos

Long-term prostacyclin reduces pulmonary vascular resistance in severe primary pulmonary hypertension

¹Columbia-Presbyterian Medical Center, Babies Hospital, Division of Pediatric Cardiology, New York, New York 10032, USA.

Clinical and Experimental Rheumatology

|June 19, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Haemodynamic characterisation and heart catheterisation complications in children with pulmonary hypertension: Insights from the Global TOPP Registry (tracking outcomes and practice in paediatric pulmonary hypertension).

International journal of cardiology·2015

Pulmonary arterial hypertension: a comparison between children and adults.

The European respiratory journal·2011

A dosing/cross-development study of the multikinase inhibitor sorafenib in patients with pulmonary arterial hypertension.

Clinical pharmacology and therapeutics·2009

Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension.

International journal of clinical practice. Supplement·2008

Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension.

The journal of vascular access·2006

Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil.

The European respiratory journal·2006

See all related articles